This study shows that serum anti-PAD4, anti-PAD3/4XR abs are highly specific for RA-ILD and assoc'd w/ better lung function in RA-UIP. Small patient sample. Potential prognostic biomarker? @RheumNow #ACR20 abs1200 https://t.co/f5VFjJhVXF

Patients with hyperCKemia (Sxs or not) and positive myositis Abs are more likely to have a positive Muscle Bx and Dx of inflammatory myositis - Single center study. #ACR20 Abstr#1074 https://t.co/vnsxmPTuPu https://t.co/qEseldIQ7x

• https://meet.acrconvergence.org/meetings/virtual/hMgrXkLsTKFhqCJYm

Biosimilars are not just about savings. More manufacturers can mean innovation: better programs/devices pursuing new indications eg COVID sc formulations CT-P13 infliximab biosimilar: immunogenicity sc vs iv same. Particularly useful in pandemic times! #ACR20 ABST1208 @RheumNow https://t.co/WjJ6OOST55

#ACR20 Dr. M. Crow on Lupus #StateofArtLecture ANA prevalence is increasing over time-- unclear why. @RheumNow https://t.co/BMTzxuhvLh

SELECT-PsA1 results UPA showed improvements in PROs vs PBO at 12 weeks in biologic DMARD-naïve patients w/ active PsA, which were maintained or further improved at Week 24. #ABS1341 #ACR20 @RheumNow https://t.co/q5tYItFb6g https://t.co/4QilMDBaXc

• Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis w…

Analysis across the lifecourse shows early exposure to passive #smoking is associated with incident seropositive #rheumatoidarthritis in adulthood- results from @kaz_yos and colleagues. Abs#1000 #ACR20 @RheumNow https://t.co/MboLBGk9yv

• Passive Smoking Throughout the Life Course and the Risk of Incident Rheumatoid …

Will you use belimumab in lupus nephritis? Abstr#1441 @RheumNow @CRASCRRheum #ACR20

Another great thieves market imaging - whole body pain after starting antifungal? Check out TM17 for diagnosis! #acr20 @RheumNow https://t.co/8VIGi7mbMY

Unilateral hip pain in a 27 yo male w/ hx of dermatomyositis on IVIG, MMF, & GC. MRI image below. What’s your diagnosis? Biopsy or no biopsy? Check out Thieves Market poster 19 by Dr. Son from @jhrheumatology. #ACR20 @RheumNow https://t.co/g9R1bB4LeS

Dr @Juge_P_A @PhilippeDieude in abstr#1195 present that MUC5B promoter variant not associated with disease progression or need for transplant in RA-ILD. Interesting, as it is associated with both RA-ILD and IPF, and with a better prognosis in IPF #ACR20 @rheumnow https://t.co/2Kdpq73AIP

Dr @Juge_P_A @PhilippeDieude on potential role for MUC5B genotyping in risk stratification for RA-ILD. Makes sense but need to clarify exact role. Abst#1194 #ACR20 @rheumnow https://t.co/crLfz2duWF

Good images of multicentric reticulohistiocytosis: note the DIP involvement as a tip off! TM14 @RheumNow #ACR20. https://t.co/Za4X0WTdtb

64 yo Indian F w/ previous dx of RA presents w/ skin lesions & arthritis (images below) in setting of high CRP, neg RF & CCP, ANA 1:80 speckled? What’s your diagnosis? Check our TM poster 14 for the answer! #ACR20 @RheumNow https://t.co/A11TDrwRga

PREVENT study: SEC provided clinically meaningful improvement in back pain, morning stiffness, fatigue, & physical function in TNFi-naïve nr-axSpA pts over 52 weeks. #ABS1340 #ACR20 @RheumNow https://t.co/RugzhqbY2A https://t.co/5kaZWoYk9t

• Secukinumab Improves Pain, Morning Stiffness, Fatigue and Physical Function in …

Gout ^CV events but hard to unravel as an independent risk as so many with gout have CRF, HTN, metabolic syndrome. But beware and get CV risk factors treated in gout pts abstr#950 @RheumNow @CRASCRRheum #ACR20 https://t.co/xYxE0xpCOj

• https://twitter.com/richardpaconway/status/1325197586756632576